Notice of Establishment, 73015 [05-23797]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 235 / Thursday, December 8, 2005 / Notices
Dated: December 1, 2005.
Elizabeth M. Duke,
Administrator.
[FR Doc. E5–7063 Filed 12–7–05; 8:45 am]
To ensure full and complete public
comment from affected outside research
institutions and associations, we are
extending the public comment period
for this notice until January 30, 2006.
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 5, 2005.
Joel Schaer,
Regulations Officer.
[FR Doc. E5–7086 Filed 12–7–05; 8:45 am]
Office of Inspector General
BILLING CODE 4152–01–P
Draft OIG Compliance Program
Guidance for Recipients of PHS
Research Awards—Extension of
Comment Period
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Inspector General
(OIG), HHS.
ACTION: Notice and comment period;
extension of comment period.
AGENCY:
Notice of Establishment
On November 28, 2005, we
published a notice and comment period
seeking comments from interested
parties on draft compliance program
guidance (CPG) developed by the Office
of Inspector General (OIG) for recipients
of extramural research awards from the
National Institutes of Health and other
agencies of the U.S. Public Health
Service (PHS) (70 FR 71312). To
facilitate public comment, we are
extending the comment period.
DATES: To assure consideration, public
comments must be delivered to the
address provided below by no later than
5 p.m. on January 30, 2006.
ADDRESSES: Please mail or deliver
written comments to the following
address: Office of Inspector General,
Department of Health and Human
Services, Attention: OIG–1026–CPG,
Room 5246, Cohen Building, 330
Independence Avenue, SW.,
Washington, DC, 20201.
We do not accept comments by
facsimile (FAX) transmissions. In
commenting, please refer to file code
OIG–1026–CPG.
FOR FURTHER INFORMATION CONTACT: Joel
Schaer, Office of External Affairs, (202)
619–0089.
SUPPLEMENTARY INFORMATION: Through
the draft CPG notice, OIG is setting forth
its general views on the value and
fundamental principles of compliance
programs for colleges and universities
and other recipients of PHS awards for
biomedical and behavioral research and
the specific elements that these award
recipients should consider when
developing and implementing an
effective compliance program. As with
OIG’s earlier CPGs, the purpose of the
draft guidance is to encourage the use of
internal controls to effectively monitor
adherence to applicable statutes,
regulations, and program requirements.
SUMMARY:
VerDate Aug<31>2005
16:29 Dec 07, 2005
Jkt 208001
Pursuant to the Federal Advisory
Committee Act, as amended (5 U.S.C.
Appendix 2), the Director, National
Institutes of Health (NIH), announces
the establishment of the Board of
Scientific Counselors, National Center
for Biotechnology Information, National
Library of Medicine (Board).
The Board shall advise the Director,
NIH; the Deputy Director for Intramural
Research, NIH; the Director, National
Library of Medicine (NLM); and the
Director, National Center for
Biotechnology Information (NCBI),
concerning the intramural research and
development programs of the NCBI,
NLM through regularly scheduled visits
to the NLM for assessment of the
research and development programs in
progress at the NCBI, assessments of
proposed programs and evaluation of
the productivity and performance of
staff scientists.
The Board shall consist of 8 members,
including the Chair, appointed by the
Director, NIH, from authorities
knowledgeable in the fields of health
sciences, computer sciences,
information sciences, information
technology, library science, behavioral
sciences, social sciences, educational
technology, communications
engineering, molecular biology,
biochemistry, genetics, structural
chemistry, mathematics, statistics, and
multi-media development and
utilization.
Duration of this committee is
continuing unless formally determined
by the Director, NIH that termination
would be in the best public interest.
Dated: November 29, 2005.
Elias Zerhouni,
Director, National Institutes of Health.
[FR Doc. 05–23797 Filed 12–07–05; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
73015
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of a meeting of the
National Advisory Research Resources
Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contact proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Research Resources Council.
Date: January 19, 2006.
Open: 8 a.m. to 12 p.m.
Agenda: NCRR Director’s report and other
business of the Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Closed: 1 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 10, Bethesda, MD 20892.
Contact Person: Louise E. Ramm, PhD,
Deputy Director, National Center for
Research Resources, National Institutes of
Health, Building 31, Room 3B11, Bethesda,
MD 20892, 301–496–6023.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
E:\FR\FM\08DEN1.SGM
08DEN1
]]>Agencies
[Federal Register Volume 70, Number 235 (Thursday, December 8, 2005)]
[Notices]
[Page 73015]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-23797]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Notice of Establishment
Pursuant to the Federal Advisory Committee Act, as amended (5
U.S.C. Appendix 2), the Director, National Institutes of Health (NIH),
announces the establishment of the Board of Scientific Counselors,
National Center for Biotechnology Information, National Library of
Medicine (Board).
The Board shall advise the Director, NIH; the Deputy Director for
Intramural Research, NIH; the Director, National Library of Medicine
(NLM); and the Director, National Center for Biotechnology Information
(NCBI), concerning the intramural research and development programs of
the NCBI, NLM through regularly scheduled visits to the NLM for
assessment of the research and development programs in progress at the
NCBI, assessments of proposed programs and evaluation of the
productivity and performance of staff scientists.
The Board shall consist of 8 members, including the Chair,
appointed by the Director, NIH, from authorities knowledgeable in the
fields of health sciences, computer sciences, information sciences,
information technology, library science, behavioral sciences, social
sciences, educational technology, communications engineering, molecular
biology, biochemistry, genetics, structural chemistry, mathematics,
statistics, and multi-media development and utilization.
Duration of this committee is continuing unless formally determined
by the Director, NIH that termination would be in the best public
interest.
Dated: November 29, 2005.
Elias Zerhouni,
Director, National Institutes of Health.
[FR Doc. 05-23797 Filed 12-07-05; 8:45 am]
BILLING CODE 4140-01-M
